|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$746,879
|
$149,376
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-03
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-13
|
$360,039
|
$32,404
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
2U10CA052784-20
|
$359,518
|
$3,595
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S1
|
$100,001
|
$1,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S2
|
$197,549
|
$1,975
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-02
|
$362,088
|
$362,088
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$1,999
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$1,480
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$1,980
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$129,282
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
US Military Cancer Institute/NCI Collaborative Research Program
|
ZIA CP010183 10382
|
$130,224
|
$6,511
|
Zahm, Shelia
|
DCEG (NCI)
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-08
|
$2,158,273
|
$151,079
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
1R01CA138744-01A1
|
$348,600
|
$348,600
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$10,002
|
$1,000
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Toward Defining the Functional Methylome in Acute Lymphoblastic Leukemia
|
5K99CA132784-02
|
$115,638
|
$115,638
|
TAYLOR, KRISTEN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
|
5K08CA134649-03
|
$127,170
|
$127,170
|
Li, Qing
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
5R01CA129382-03
|
$337,189
|
$168,595
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-17S1
|
$75,066
|
$1,501
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-17S2
|
$100,000
|
$2,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-17
|
$5,047,305
|
$100,946
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S4
|
$3,823,791
|
$114,714
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S5
|
$100,000
|
$3,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S6
|
$50,000
|
$1,500
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S7
|
$80,000
|
$2,400
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S8
|
$200,000
|
$6,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The glucocorticoid receptor as signal integrator: studying ALL drug resistance
|
1K99CA149088-01
|
$115,376
|
$115,376
|
PUFALL, MILES
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
|
1U01CA151837-01
|
$492,410
|
$492,410
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
5R01CA136551-02
|
$560,754
|
$280,377
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy for 11q23 acute leukemias
|
5R01CA098459-05
|
$202,994
|
$101,497
|
HEMENWAY, CHARLES
|
LOYOLA UNIVERSITY CHICAGO
|
|
t(8;21) and SON in Blood Cell Proliferation and Differentiation
|
5R01CA096735-08
|
$354,471
|
$88,618
|
ZHANG, DONG-ER
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
5R01CA136912-02
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
3U24CA114766-05S1
|
$1,195,618
|
$239,124
|
Ramirez, Nilsa
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Studies of BCR/ABL Leukemogenesis in Mice
|
5R01CA090576-11
|
$286,110
|
$143,055
|
Van Etten, Richard
|
TUFTS MEDICAL CENTER
|
|
Stanford University Cancer Center
|
2P30CA124435-04
|
$3,254,335
|
$32,543
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
3P30CA124435-04S1
|
$126,467
|
$1,265
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
3P30CA124435-04S2
|
$99,467
|
$995
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
3P30CA124435-04S3
|
$100,000
|
$1,000
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-25S9
|
$100,000
|
$2,000
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-26S1
|
$39,397
|
$788
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-26S2
|
$115,875
|
$2,318
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-26S3
|
$100,000
|
$2,000
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-26S4
|
$50,000
|
$1,000
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-26
|
$4,505,660
|
$90,113
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Southeast Cancer Control Consortium, Inc
|
2U10CA045808-24
|
$2,264,660
|
$22,647
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$71,905
|
$14,381
|
Arthur, Diane
|
CCR (NCI)
|
|
Rpl22 as Biomarker of Prognosis and Therapeutic Response in T-ALL
|
1R21CA141194-01A1
|
$227,723
|
$227,723
|
WIEST, DAVID
|
INSTITUTE FOR CANCER RESEARCH
|
|
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
|
1K99CA151457-01
|
$127,899
|
$127,899
|
Tyner, Jeffrey
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Role of PBX Proteins in Hematopoiesis and Growth Control
|
5R01CA090735-10
|
$300,227
|
$300,227
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Role of miR155 in Leukemogenesis
|
7R01CA124541-03
|
$336,489
|
$168,245
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Childhood Leukemia for this search: $56,124,322
|